Sarah Laing

1.3k total citations
18 papers, 475 citations indexed

About

Sarah Laing is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Surgery. According to data from OpenAlex, Sarah Laing has authored 18 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 8 papers in Economics and Econometrics and 2 papers in Surgery. Recurrent topics in Sarah Laing's work include Pharmaceutical Economics and Policy (8 papers), Pharmaceutical Quality and Counterfeiting (8 papers) and Malaria Research and Control (3 papers). Sarah Laing is often cited by papers focused on Pharmaceutical Economics and Policy (8 papers), Pharmaceutical Quality and Counterfeiting (8 papers) and Malaria Research and Control (3 papers). Sarah Laing collaborates with scholars based in United States, United Kingdom and Australia. Sarah Laing's co-authors include Sachiko Ozawa, Daniel R. Evans, Tatenda T. Yemeke, Sophia Bessias, James E. Herrington, Phyllis Awor, Daniel Erim, Karen H. Vousden, Colin Nixon and Björn Kruspig and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Science Translational Medicine.

In The Last Decade

Sarah Laing

16 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Laing United States 10 281 233 75 66 53 18 475
Amber Jessup United States 9 162 0.6× 277 1.2× 63 0.8× 16 0.2× 7 0.1× 14 719
Kimberly Hess United States 7 189 0.7× 139 0.6× 34 0.5× 8 0.1× 29 0.5× 18 290
András Fittler Hungary 12 221 0.8× 129 0.6× 22 0.3× 9 0.1× 14 0.3× 35 460
Roger Bate United States 13 454 1.6× 395 1.7× 59 0.8× 66 1.0× 61 1.2× 70 670
Aylin Sertkaya United States 7 94 0.3× 144 0.6× 56 0.7× 6 0.1× 29 0.5× 13 432
Aqil Mohammad Daher Malaysia 14 105 0.4× 39 0.2× 67 0.9× 7 0.1× 41 0.8× 46 667
Dora Akunyili Nigeria 6 196 0.7× 146 0.6× 39 0.5× 25 0.4× 29 0.5× 7 295
Michael Lanthier United States 9 63 0.2× 213 0.9× 82 1.1× 27 0.4× 10 0.2× 12 448
Matthew Herder Canada 11 93 0.3× 139 0.6× 33 0.4× 26 0.4× 2 0.0× 55 346
Brenda Waning United States 8 84 0.3× 321 1.4× 11 0.1× 69 1.0× 24 0.5× 13 527

Countries citing papers authored by Sarah Laing

Since Specialization
Citations

This map shows the geographic impact of Sarah Laing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Laing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Laing more than expected).

Fields of papers citing papers by Sarah Laing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Laing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Laing. The network helps show where Sarah Laing may publish in the future.

Co-authorship network of co-authors of Sarah Laing

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Laing. A scholar is included among the top collaborators of Sarah Laing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Laing. Sarah Laing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Laing, Sarah. (2025). Inner Belkis. Art Therapy. 42(4). 199–199.
2.
Munro, June, Louise Mitchell, Sarah Laing, et al.. (2023). Optimisation of Sample Preparation from Primary Mouse Tissue to Maintain RNA Integrity for Methods Examining Translational Control. Cancers. 15(15). 3985–3985. 2 indexed citations
3.
Laing, Sarah, et al.. (2023). Anaesthetist prediction of postoperative opioid use: a multicentre prospective cohort study. SHILAP Revista de lepidopterología. 8. 100226–100226. 2 indexed citations
4.
Ozawa, Sachiko, et al.. (2021). Educational and economic returns to cognitive ability in low- and middle-income countries: A systematic review. World Development. 149. 105668–105668. 24 indexed citations
5.
Bui, Vy, et al.. (2021). Assessing the Impact of Substandard and Falsified Antimalarials in Benin. American Journal of Tropical Medicine and Hygiene. 106(6). 1770–1777. 3 indexed citations
6.
Laing, Sarah, et al.. (2021). Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study. SHILAP Revista de lepidopterología. 5. 9 indexed citations
7.
Laing, Sarah, et al.. (2020). An investment case for maternal and neonatal tetanus elimination. Vaccine. 38(9). 2241–2249. 2 indexed citations
8.
Laing, Sarah, Chiluba Mwila, Tamaki Kobayashi, et al.. (2020). Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model. BMC Public Health. 20(1). 1083–1083. 11 indexed citations
9.
Laing, Sarah, et al.. (2020). Infant peripherally inserted central catheter insertion without general anesthesia. Pediatric Anesthesia. 30(11). 1211–1215. 4 indexed citations
10.
Evans, Daniel R., et al.. (2019). The economic impact of substandard and falsified antimalarial medications in Nigeria. PLoS ONE. 14(8). e0217910–e0217910. 51 indexed citations
11.
Ozawa, Sachiko, et al.. (2019). Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study. Malaria Journal. 18(1). 5–5. 17 indexed citations
13.
Evans, Daniel R., et al.. (2019). Poor-quality antimalarials further health inequities in Uganda. Health Policy and Planning. 34(Supplement_3). iii36–iii47. 31 indexed citations
14.
Ozawa, Sachiko, et al.. (2019). Modeling the Economic Impact of Substandard and Falsified Antimalarials in the Democratic Republic of the Congo. American Journal of Tropical Medicine and Hygiene. 100(5). 1149–1157. 21 indexed citations
15.
Kruspig, Björn, Tiziana Monteverde, Sarah Neidler, et al.. (2018). The ERBB network facilitates KRAS-driven lung tumorigenesis. Science Translational Medicine. 10(446). 72 indexed citations
16.
Ozawa, Sachiko, Daniel R. Evans, Sophia Bessias, et al.. (2018). Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries. JAMA Network Open. 1(4). e181662–e181662. 200 indexed citations
17.
Laing, Sarah, et al.. (2009). The effects of nitrous oxide on recovery from isoflurane anaesthesia in dogs. Journal of Small Animal Practice. 50(2). 82–86. 9 indexed citations
18.
Laing, Sarah, et al.. (2005). Open Studio Process as a Model of Social Action: A Program for At-Risk Youth. Art Therapy. 22(1). 32–38. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026